Ausgewählte Publikationen Franco Guscetti

  1. Guscetti F, Nath N, Denko N, 2005. Functional characterization of human proapoptotic molecules in yeast S. cerevisiae. FASEB J 19(3), 464-466.
  2. Melzer K, Guscetti F, Rohrer Bley C, Sumova A, Roos M, Kaser-Hotz B, 2006. Ki67 immunoreactivity in nasal and periocular squamous cell carcinomas in cats treated with electron beam radiation therapy. J Vet Intern Med 20(3), 676-681.
  3. Inteeworn N, Ohlerth N, Höpfl G, Guscetti F, Rohrer Bley C, Wergin MC, Roos M, Gassmann M, Kaser-Hotz B, 2007. Simultaneous application of the vascular endothelial growth factor (VEGF) receptor inhibitor PTK787/ZK 222584 and ionizing radiation does not further reduce the growth of canine oral melanoma xenografts in nude mice. Vet J 173(3), 564-570.
  4. Keller SM, Schade B, Rickenbacher AB, Brugnera E, Wergin MC, Müller EJ, Suter MM, Guscetti F, 2007. A comprehensive test system to identify suitable antibodies against p53 for immunohistochemical analysis of canine tissues. J Comp Path 137(1), 59-70.
  5. Keller SM, Keller BC, Grest P, Börger CT, Guscetti F, 2007. Validation of tissue microarrays for immunohistochemical analyses of canine lymphomas. J Vet Diagn Invest 19(6), 652-659.
  6. Favrot C, Welle M, Heimann M, Godson DL, Guscetti F, 2009. Clinical, histologic, and immunohistochemical analyses of feline squamous cell carcinoma in situ. Vet Pathol 46, 25-33.
  7. Eckstein C, Guscetti F, Roos M, Martin de las Mulas J, Kaser-Hotz B, Rohrer-Bley C, 2009. A retrospective analysis of radiation therapy for the treatment of feline vaccine-associated sarcoma. Vet Comp Oncol 7(1), 54-68.
  8. Wimmershoff J, Polkinghorne A, Grest P, Schade B, Marchal T, Keller SM, Guscetti F, 2010. Immunohistochemical detection of survivin in canine lymphoma. J Comp Path 142(4), 311-322.
  9. Guil-Luna S, Sánchez-Céspedes R, Millán Y, De Andrés FJ, Rollón E, Domingo V, Guscetti F, Martín de las Mulas J, 2011. Aglepristone reduces proliferation in progesterone receptor-positive canine mammary carcinomas. J Vet Intern Med 25(3), 518-523
  10. Michel E, Feldmann SK, Kowalewski MP, Rohrer Bley C, Boos A, Guscetti F, Reichler IM, 2012. Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas. BMC Vet Res 8, 72 doi:10.1186/1746-6148-8-72.
  11. Pospischil A, Hässig M, Vogel R, Salvini MM, Fabrikant S, Axhausen K, Schenker NS, Erni D, Guscetti F, 2013. Hundepopulation und Hunderassen in der Schweiz von 1955 bis 2008. Schweiz Arch Tierheilk 155(4), 219-228.
  12. Dettwiler M, Croci M, Vaughan L, Guscetti F, 2013. Immunohistochemical expression study of proapoptotic BH3-only protein Bad in canine nonneoplastic tissues and canine lymphomas. Vet Pathol 50(5), 789-796.
  13. Croci M, Dettwiler M, Vaughan L, Guscetti F, 2013. Immunohistochemical expression of Bax and Bak in canine non-neoplastic tissues. Vet J 198, 131-140.
  14. van Sprundel RG, van den Ingh TS, Guscetti F, Kershaw O, Kanemoto H, Van Gils HM, Rothuizen J, Roskams T, Spee B, 2013. New prognostic classification of primary hepatic tumours in the dog. Vet J 197(3), 596-606.
  15. Comazzi S, Guscetti F, Marconato L, 2014. First meeting of the European canine lymphoma group. Workshop: state of the art and comparative aspects in canine lymphoma. CH-Lugano, June 22nd, 2013. Hematol Oncol 32(2), 68-71.